货号：UP216228573
| 产品信息 | |
| 产品名称： | PI-103 |
| 中文名称： | PI-103(请以英文为准,中文仅做参考) |
| CAS号： | 371935-74-9 |
| 分子式： | C19H16N4O3 |
| 分子量： | 348.36 |
| MDL NO： | MFCD11983145 |
| 标准纯度： | 98+% (UP216228573) |
| 沸点： | 520.25°C at 760 mmHg |
| 储存： | Keep in dark place,Sealed in dry,Store in freezer, under -20°C (UP216228573) |
| Pubchem ID： | - |
| ACS编号： | - |
| InChIKey： | - |
| Clogp | - |
| 英文别名： | - |
| 中文别名 | - |
Dalbergioidin
UP39250900730368-42-4
10058-F4
UP791123840403811-55-2
CBB1003
UP6818203821379573-88-2
OT-R antagonist 2
UP166856464364071-16-9
Phenethyl methanesulfonate
UP65708084320020-27-3
LCZ 696
UP817517371936623-90-4
GSK-J4 Hydrochloride
UP4564320871797983-09-5
Citarinostat
UP2712618951316215-12-9
GSK-J1 Lithium
UP1138288431373422-39-9
BG45
UP243519941926259-99-6
4-Hexylbenzene-1,3-diol
UP881691274136-77-6
PJ34 hydrochloride
UP974288188344458-15-7
Tecovirimat
UP457856152869572-92-9
Panobinostat
UP720308100404950-80-7
Vorapaxar
UP915034527618385-01-6
Volasertib
UP603731721755038-65-4
K-Ras G12C-IN-3
UP3359725221629268-19-4
GSK-LSD1 Dihydrochloride
UP6857913871821798-25-7
ML324
UP3621026231222800-79-4
(R)-Sulforaphane
UP887608592142825-10-3
TRAP-6
UP419858883141136-83-6
Divalproex Sodium
UP65196342276584-70-8
PAF (C16)
UP65028456574389-68-7
AC-55541
UP531840142916170-19-9
4''-(Pentyloxy)-[1,1':4',1''-terphenyl]-4-carboxylic acid
UP542100014158938-08-0
CJ-42794
UP376670283847728-01-2
Sodium Butyrate
UP323381953156-54-7
Candesartan
UP336379503139481-59-7
Fisetin
UP927427173528-48-3
Tasosartan
UP198083864145733-36-4
Azilsartan
UP979700808147403-03-0
Oxytocin
UP67044909650-56-6
MG-132
UP890361061133407-82-6
Nicotinamide
UP33704827898-92-0
Otenabant Hydrochloride
UP303622407686347-12-6
PI-103
UP216228573371935-74-9